Models of breast cancer: is merging human and animal models the future?
AUTOR(ES)
Kim, Jong B
FONTE
BioMed Central
RESUMO
Survival rates of patients with early breast cancer in the United Kingdom and in the United States have improved steadily over the past 15 years. The only way to continue or even accelerate this progress, however, is the discovery and development of new preventative and therapeutic strategies. With the massive explosion in potential therapeutic strategies becoming available, in the postgenomic era, better and more representative breast cancer models are urgently required for preclinical trials. Development of better in vivo models of human breast cancer are thus of crucial importance in the development of new cancer therapeutics.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=314443Documentos Relacionados
- Models of breast cancer: quo vadis, animal modeling?
- The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
- Future possibilities in the prevention of breast cancer: Breast cancer prevention trials
- Future possibilities in the prevention of breast cancer: Fat and fiber and breast cancer research
- Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies
